Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13982 | 800 | 28.8 | 41% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
57 | 3 | ANGIOTENSIN II//HYPERTENSION//PERIPHERAL VASCULAR DISEASES | 89232 |
2888 | 2 | HEART KIDNEY//FENOLDOPAM//IBOPAMINE | 2830 |
13982 | 1 | INTRATHECAL DOMPERIDONE//SPINAL DOPAMINE D 2 RECEPTORS//HYPOTENSION AND BRADYCARDIA | 800 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INTRATHECAL DOMPERIDONE | authKW | 114503 | 0% | 100% | 3 |
2 | SPINAL DOPAMINE D 2 RECEPTORS | authKW | 114503 | 0% | 100% | 3 |
3 | HYPOTENSION AND BRADYCARDIA | authKW | 76336 | 0% | 100% | 2 |
4 | MONOSYNAPTIC MASS REFLEX | authKW | 76336 | 0% | 100% | 2 |
5 | PERGOLIDE GENERAL PHARMACOLOGY | authKW | 76336 | 0% | 100% | 2 |
6 | PROPRANOLOL PRETREATMENT | authKW | 76336 | 0% | 100% | 2 |
7 | I 125 NCQ 298 | authKW | 50889 | 0% | 67% | 2 |
8 | NORMOTENSIVE RAT | authKW | 50213 | 1% | 26% | 5 |
9 | PRESYNAPTIC DOPAMINE RECEPTORS | authKW | 49069 | 0% | 43% | 3 |
10 | 870 | authKW | 38168 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 3645 | 40% | 0% | 320 |
2 | Endocrinology & Metabolism | 2628 | 23% | 0% | 182 |
3 | Physiology | 418 | 9% | 0% | 70 |
4 | Peripheral Vascular Diseases | 355 | 7% | 0% | 55 |
5 | Cardiac & Cardiovascular System | 306 | 9% | 0% | 71 |
6 | Neurosciences | 290 | 13% | 0% | 107 |
7 | Medicine, Research & Experimental | 226 | 7% | 0% | 59 |
8 | Chemistry, Medicinal | 19 | 2% | 0% | 18 |
9 | Medicine, General & Internal | 18 | 4% | 0% | 32 |
10 | Multidisciplinary Sciences | 6 | 1% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AHMET NECDET SEZER UYGULAMA ARASTIRMA HASTANESI | 38168 | 0% | 100% | 1 |
2 | CARDIOVASC ULTRASOUND UNIT | 38168 | 0% | 100% | 1 |
3 | ENDOCRINOL R BOTUCATU 720 CP 2066 | 38168 | 0% | 100% | 1 |
4 | ENDOCRINOL SAN FERNANDO VALLEY PROGRAM | 38168 | 0% | 100% | 1 |
5 | EXPTL CLIN ENDOCRINOLROBERT KOCH STR 40 | 38168 | 0% | 100% | 1 |
6 | HORMONAL REGULAT METAB | 38168 | 0% | 100% | 1 |
7 | HORMONE ISOTOPE | 38168 | 0% | 100% | 1 |
8 | HOSP CLIN MED PHARMACOL | 38168 | 0% | 100% | 1 |
9 | INTERNAL MED CARDIOVASC UNIT | 38168 | 0% | 100% | 1 |
10 | KOMISSARENKO ENDOCRINOL | 38168 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE | 13461 | 3% | 2% | 22 |
2 | ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE | 4860 | 2% | 1% | 17 |
3 | JOURNAL OF AUTONOMIC PHARMACOLOGY | 3667 | 1% | 1% | 9 |
4 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 3069 | 6% | 0% | 44 |
5 | JOURNAL DE PHARMACOLOGIE | 2839 | 1% | 1% | 5 |
6 | FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2255 | 1% | 1% | 11 |
7 | HORMONE AND METABOLIC RESEARCH | 1931 | 2% | 0% | 18 |
8 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1813 | 4% | 0% | 32 |
9 | EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY | 1682 | 1% | 1% | 7 |
10 | CLINICAL ENDOCRINOLOGY | 1447 | 2% | 0% | 17 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LAHLOU, S , DUARTE, GP , (1998) HYPOTENSIVE ACTION OF BROMOCRIPTINE IN THE DOCA-SALT HYPERTENSIVE RAT: CONTRIBUTION OF SPINAL DOPAMINE RECEPTORS.FUNDAMENTAL & CLINICAL PHARMACOLOGY. VOL. 12. ISSUE 6. P. 599-606 | 32 | 80% | 0 |
2 | MANNELLI, M , LAZZERI, C , IANNI, L , LAVILLA, G , PUPILLI, C , BELLINI, F , SERIO, M , FRANCHI, F , (1997) DOPAMINE AND SYMPATHOADRENAL ACTIVITY IN MAN.CLINICAL AND EXPERIMENTAL HYPERTENSION. VOL. 19. ISSUE 1-2. P. 163 -179 | 31 | 69% | 20 |
3 | LAHLOU, S , (2002) BLOCKADE OF SPINAL DOPAMINE D-2 RECEPTORS ENHANCES THE PRESSOR EFFECT OF INTRAVENOUS QUINPIROLE IN NORMOTENSIVE, CONSCIOUS RATS.PHARMACOLOGY & TOXICOLOGY. VOL. 90. ISSUE 2. P. 94 -99 | 26 | 70% | 1 |
4 | LAHLOU, S , (1998) INVOLVEMENT OF SPINAL DOPAMINE RECEPTORS IN MEDIATION OF THE HYPOTENSIVE AND BRADYCARDIC EFFECTS OF SYSTEMIC QUINPIROLE IN ANAESTHETISED RATS.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 353. ISSUE 2-3. P. 227 -237 | 28 | 70% | 11 |
5 | LAHLOU, S , (2000) BLUNTED PRESSER RESPONSIVENESS TO INTRAVENOUS QUINPIROLE IN CONSCIOUS, CHRONIC SPINAL CORD-TRANSECTED RATS: PERIPHERAL VS. SPINAL MECHANISMS.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 408. ISSUE 1. P. 51 -62 | 28 | 64% | 2 |
6 | FRASER, R , CONNELL, JMC , INGLIS, G , KENYON, CJ , TREE, M , (1989) THE ROLE OF DOPAMINE IN THE CONTROL OF CORTICOSTEROID SECRETION AND METABOLISM.JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. VOL. 32. ISSUE 1B. P. 217-222 | 42 | 64% | 17 |
7 | CUCHE, JL , (1988) DOPAMINERGIC CONTROL OF ALDOSTERONE SECRETION - STATE-OF-THE-ART REVIEW.FUNDAMENTAL & CLINICAL PHARMACOLOGY. VOL. 2. ISSUE 4. P. 327-339 | 33 | 85% | 19 |
8 | TOSCANO, CF , LAHLOU, S , (2003) BLOOD PRESSURE EFFECTS OF INTRAVENOUS APOMORPHINE IN CONSCIOUS DEOXYCORTICOSTERONE-ACETATE SALT-HYPERTENSIVE RATS.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 42. ISSUE 6. P. 772-781 | 21 | 72% | 1 |
9 | LAHLOU, S , (1999) CARDIOVASCULAR RESPONSES TO INTRATHECAL DOPAMINE RECEPTOR AGONISTS IN CONSCIOUS DOCA-SALT HYPERTENSIVE RATS.FUNDAMENTAL & CLINICAL PHARMACOLOGY. VOL. 13. ISSUE 6. P. 624-634 | 22 | 76% | 2 |
10 | WU, KD , CHEN, YM , CHU, TS , CHUEH, SC , WU, MH , HSIEH, BS , (2001) EXPRESSION AND LOCALIZATION OF HUMAN DOPAMINE D2 AND D4 RECEPTOR MRNA IN THE ADRENAL GLAND, ALDOSTERONE-PRODUCING ADENOMA, AND PHEOCHROMOCYTOMA.JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. VOL. 86. ISSUE 9. P. 4460 -4467 | 23 | 59% | 28 |
Classes with closest relation at Level 1 |